GRIA2 and chronic kidney disease: Given the lack of sensitivity changes to NASPM between the cKD and control groups, as well as the lack of rectification of AMPAR-EPSCs, GluA2-containing CI-AMPARs may be prime candidates for preferential synaptic recruitment36.